Stay updated on Anti-viral Therapy in Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page.

Latest updates to the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the valacyclovir Alzheimer’s disease study is now displayed, including its study design, eligibility criteria, locations, outcome measures, and publications.SummaryDifference52%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA notice about NIH’s terminology transition appears above the page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the expected study details and preventing access to the record.SummaryDifference19%

- Check60 days agoChange DetectedThe page revision badge was updated from v3.6.6 to v3.7.0. This signals a backend or UI update behind the scenes rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Anti-viral Therapy in Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-viral Therapy in Alzheimer's Disease Clinical Trial page.